DIRC3 acts in the nucleus and has been shown to activate expression of the neighbouring insulin-like growth factor binding protein 5 (IGFBP5) gene, which shapes tumour suppression by modulating the insulin-like growth factor 1 receptor (IGF1R) pathway. This evidence concerns the gene DIRC3 and neoplasm.